[1] PUJAR S,SCOTT R C.Long-term outcomes after childhood convulsive status epilepticus[J].Curr Opin Pediatr,2019,31(6):763-768.
[2] JOSEPHSON C B,LOWERISON M,VALLERAND I,et al.Association of depression and treated depression with epilepsy and seizure outcomes:a multicohort analysis[J].JAMA Neurol,2017,74(5):533-539.
[3] GAITATZIS A,SANDER J W.The mortality of epilepsy revisited[J].Epileptic Disord,2004,6(1):3-13.
[4] MERLET I,OSTROWSKY K,COSTES N,et al.5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy:an[18F]MPPF-PET study[J].Brain,2004,127(Pt 4):900-913.
[5] GILLIAM F G,MATON B M,MARTIN R C,et al.Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy[J].Neurology,2007,68(5):364-368.
[6] PENG W F,DING J,MAO L Y,et al.Increased ratio of glutamate/glutamine to creatine in the right hippocampus contributes to depressive symptoms in patients with epilepsy[J].Epilepsy Behav,2013,29(1):144-149.
[7] PENG W,MAO L,YIN D,et al.Functional network changes in the hippocampus contribute to depressive symptoms in epilepsy[J].Seizure,2018,60:16-22.
[8] ZHU X,HE Z,LUO C,et al.Altered spontaneous brain activity in MRI-negative refractory temporal lobe epilepsy patients with major depressive disorder:a resting-state fMRI study[J].J Neurol Sci,2018,386:29-35.
[9] SALZBERG M,TAHER T,DAVIE M,et al.Depression in temporal lobe epilepsy surgery patients:an FDG-PET study[J].Epilepsia,2006,47(12):2125-2130.
[10] PEREZ E L,LAURITZEN F,WANG Y,et al.Evidence for astrocytes as a potential source of the glutamate excess in temporal lobe epilepsy[J].Neurobiol Dis,2012,47(3):331-337.
[11] LIBRIZZI L,NOō F,VEZZANI A,et al.Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage[J].Ann Neurol,2012,72(1):82-90.
[12] JUKKOLA P,GU C.Regulation of neurovascular coupling in autoimmunity to water and ion channels[J].Autoimmun Rev,2015,14(3):258-267.
[13] HUBBARD J A,SZU J I,YONAN J M,et al.Regulation of astrocyte glutamate transporter-1(GLT1) and aquaporin-4(AQP4) expression in a model of epilepsy[J].Exp Neurol,2016,283(Pt A):85-96.
[14] KONG H,ZENG X N,FAN Y,et al.Aquaporin-4 knockout exacerbates corticosterone-induced depression by inhibiting astrocyte function and hippocampal neurogenesis[J].CNS Neurosci Ther,2014,20(5):391-402.
[15] DI BENEDETTO B,MALIK V A,BEGUM S,et al.Fluoxetine requires the endfeet protein aquaporin-4 to enhance plasticity of astrocyte processes[J].Front Cell Neurosci,2016,10:8.
[16] ZHAO X,LIAO Y,MORGAN S,et al.Noninflammatory changes of microglia are sufficient to cause epilepsy[J].Cell Rep,2018,22(8):2080-2093.
[17] SEPULVEDA-RODRIGUEZ A,LI P,KHAN T,et al.Electroconvulsive shock enhances responsive motility and purinergic currents in microglia in the mouse hippocampus[J].eNeuro,2019,6(2):19-56.
[18] MCNALLY L,BHAGWAGAR Z,HANNESTAD J.Inflammation,glutamate,and glia in depression:a literature review[J].CNS Spectr,2008,13(6):501-510.
[19] XIE W,CAI L,YU Y,et al.Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy[J].J Neuroinflammation,2014,11:1-10.
[20] SINGH T,KAUR T,GOEL R K.Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression[J].Neurochem Int,2017,104:27-33.
[21] TAO H,GONG Y,YU Q,et al.Elevated serum matrix metalloproteinase-9,interleukin-6,hypersensitive C-reactive protein,and homocysteine levels in patients with epilepsy[J].J Interferon Cytokine Res,2020,40(3):152-158.
[22] 朱晓琴,李正莉,朱长庚,等.白细胞介素-1β或白细胞介素-6致痫大鼠脑内γ-氨基丁酸和谷氨酸免疫反应性的变化[J].解剖学报,2005(6):10-14.
[23] LORIGADOS PEDRE L,MORALES CHACÓN L M,PAVÓN FUENTES N,et al.Follow-up of peripheral IL-1β and IL-6 and relation with apoptotic death in drug-resistant temporal lobe epilepsy patients submitted to surgery[J].Behavioral Sciences,2018,8(2):21.
[24] VIEIRA E L,DE OLIVEIRA G N,LESSA J M,et al.Interleukin-1beta plasma levels are associated with depression in temporal lobe epilepsy[J].Epilepsy Behav,2015,53:131-134.
[25] EUGENIN E A,ECKARDT D,THEIS M,et al.Microglia at brain stab wounds express connexin 43 and in vitro form functional gap junctions after treatment with interferon-gamma and tumor necrosis factor-alpha[J].Proc Natl Acad Sci U S A,2001,98(7):4190-4195.
[26] MALETIC V,ROBINSON M,OAKES T,et al.Neurobiology of depression:an integrated view of key findings[J].Int J Clin Pract,2007,61(12):2030-2040.
[27] REYNOLDS J L,IGNATOWSKI T A,SUD R,et al.An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission[J].Neuroscience,2005,133(2):519-531.
[28] CLARK I A,ALLEVA L M,VISSEL B.The roles of TNF in brain dysfunction and disease[J].Pharmacol Ther,2010,128(3):519-548.
[29] GARNER J M,CHAMBERS J,BARNES A K,et al.Changes in brain-derived neurotrophic factor expression influence sleep-wake activity and homeostatic regulation of rapid eye movement sleep[J].Sleep,2018,41(2):x194.
[30] POPOVA N K,NAUMENKO V S.Neuronal and behavioral plasticity:the role of serotonin and BDNF systems tandem[J].Expert Opin Ther Targets,2019,23(3):227-239.
[31] DE ALMEIDA A A,GOMES D S S,LOPIM G M,et al.Physical exercise alters the activation of downstream proteins related to BDNF-TrkB signaling in male Wistar rats with epilepsy[J].J Neurosci Res,2018,96(5):911-920.
[32] GIOVACCHINI G,TOCZEK M T,BONWETSCH R,et al.5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction[J].J Nucl Med,2005,46(7):1128-1135.
[33] KUGAYA A,SANACORA G.Beyond monoamines:glutamatergic function in mood disorders[J].CNS Spectr,2005,10(10):808-819.
[34] EID T,HAMMER J,RUNDÉN-PRAN E,et al.Increased expression of phosphate-activated glutaminase in hippocampal neurons in human mesial temporal lobe epilepsy[J].Acta Neuropathol,2007,113(2):137-152.
[35] MALTHANKAR-PHATAK G H,DE LANEROLLE N,EID T,et al.Differential glutamate dehydrogenase (GDH) activity profile in patients with temporal lobe epilepsy[J].Epilepsia,2006,47(8):1292-1299.
[36] WANG Y,LIAO J,TANG S J,et al.HIV-1 gp120 upregulates brain-derived neurotrophic factor (BDNF) expression in BV2 cells via the Wnt/beta-catenin signaling pathway[J].J Mol Neurosci,2017,62(2):199-208.
[37] XU L Z,XU D F,HAN Y,et al.BDNF-GSK-3beta-beta-catenin pathway in the mPFC is involved in antidepressant-like effects of morinda officinalis oligosaccharides in rats[J].Int J Neuropsychopharmacol,2017,20(1):83-93.
[38] QU Z,SU F,QI X,et al.Wnt/beta-catenin signalling pathway mediated aberrant hippocampal neurogenesis in kainic acid-induced epilepsy[J].Cell Biochem Funct,2017,35(7):472-476.
[39] LOPEZ J P,FIORI L M,CRUCEANU C,et al.MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes[J].Nat Commun,2017,8:1-12.
[40] SINGH S,MISHRA A,SRIVASTAVA N,et al.MK-801(Dizocilpine) regulates multiple steps of adult hippocampal neurogenesis and alters psychological symptoms via Wnt/β-catenin signaling in Parkinsonian rats[J].ACS Chem Neurosci,2017,8(3):592-605.
[41] PENG H,WANG H,WANG L,et al.Gsk3 β aggravates the depression symptoms in chronic stress mouse model[J].J Integr Neurosci,2018,17(2):217-226.
[42] GE J,XU Y,QIN G,et al.Resveratrol ameliorates the anxiety-and depression-like behavior of subclinical hypothyroidism rat:possible involvement of the HPT axis,HPA axis,and Wnt/β-catenin pathway[J].Front Endocrinol,2016,7:44.
[43] ZHOU W J,XU N,KONG L,et al.The antidepressant roles of Wnt2 and Wnt3 in stress-induced depression-like behaviors[J].Transl Psychiatry,2016,6(9):e892.
[44] DE OLIVEIRA G N,LESSA J M K,GONÇALVES A P,et al.Screening for depression in people with epilepsy:comparative study among neurological disorders depression inventory for epilepsy (NDDI-E),hospital anxiety and depression scale depression subscale (HADS-D),and Beck depression inventory (BDI)[J].Epilepsy Behav,2014,34:50-54.
[45] KANNER A M,KOZAK A M,FREY M.The use of sertraline in patients with epilepsy:is it safe?[J].Epilepsy Behav,2000,1(2):100-105.
[46] NOBLE A J,REILLY J,TEMPLE J,et al.Cognitive-behavioural therapy does not meaningfully reduce depression in most people with epilepsy:a systematic review of clinically reliable improvement[J].J Neurol Neurosurg Psychiatry,2018,89(11):1129-1137.
[47] ORJUELA-ROJAS J M,MARTINEZ-JUAREZ I E,RUIZ-CHOW A,et al.Treatment of depression in patients with temporal lobe epilepsy:a pilot study of cognitive behavioral therapy vs.selective serotonin reuptake inhibitors[J].Epilepsy Behav,2015,51:176-181.
[48] FISHER P L,NOBLE A J.Anxiety and depression in people with epilepsy:the contribution of metacognitive beliefs[J].Seizure,2017,50:153-159.
[49] NOBLE A J,REILLY J,TEMPLE J,et al.Cognitive-behavioural therapy does not meaningfully reduce depression in most people with epilepsy:a systematic review of clinically reliable improvement[J].J Neurol Neurosurg Psychiatry,2018,89(11):1129-1137.
[50] HAMID H,KANNER A M.Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?[J].Epilepsy Behav,2013,26(3):261-265. |
